A detailed history of Arlington Trust CO LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Arlington Trust CO LLC holds 10,837 shares of EW stock, worth $822,745. This represents 0.16% of its overall portfolio holdings.

Number of Shares
10,837
Previous 11,450 5.35%
Holding current value
$822,745
Previous $1.06 Million 32.36%
% of portfolio
0.16%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$59.7 - $93.78 $36,596 - $57,487
-613 Reduced 5.35%
10,837 $715,000
Q2 2024

Aug 06, 2024

SELL
$84.3 - $94.31 $70,137 - $78,465
-832 Reduced 6.77%
11,450 $1.06 Million
Q1 2024

Apr 16, 2024

SELL
$72.54 - $95.56 $1,740 - $2,293
-24 Reduced 0.2%
12,282 $1.17 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $744,777 - $938,485
12,069 Added 5092.41%
12,306 $938,000
Q3 2023

Oct 24, 2023

BUY
$69.28 - $93.38 $16,419 - $22,131
237 New
237 $16,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.